Alamar Biosciences, Inc. (ALMR) Stock Analysis & Investment Frameworks
Alamar Biosciences, Inc. (ALMR) stock analysis on Invetso. Review Alamar Biosciences, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Alamar Biosciences, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Alamar Biosciences, Inc. Key Financial Metrics
- Market Cap: $1.87B
- Revenue: $74.21M
- ROE: -68.49%
- ROIC: -11.82%
- Dividend Yield: N/A
About Alamar Biosciences, Inc.
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.